Table 2.

Baseline characteristics of patients randomized to MMF/DEX

Baseline FactorAll Randomized(n = 66)Patients in This Substudy (C) (n = 20)Patients not in This Substudy (D) (n = 46)P Value (C) versus (D)
Age at Enrollment (yr)14.5 (6–35)14 (9.5–34.5)15 (5–35)0.68
White race38 (57.6)13 (65.0)25 (54.3)0.71
Male sex33 (50)12 (60.0)21 (45.6)0.42
Baseline GFR (ml/min per 1.73m2)132.0 ± 73.6122.6 ± 50.7136.2 ± 81.70.49
UP/C (mg/mg)3.7 (1.2–13.1)3.6 (1.1–9.6)4.0 (1.5–13.6)0.17
Serum albumin (g/d)2.7 (1.6–4.0)3.2 (1.9–4.0)2.6 (1.5–4.0)0.10
Serum cholesterol (mg/dl)312 (221–569)271.5 (187–480)365 (232–589)0.02
Hypertensive39 (59.1)13 (65.0)26 (56.5)0.59
  • Data shown as median (10th–90th percentile), n (%), or mean ± SD. MMF/DEX, mycophenolate mofetil/dexamethasone; UP/C, urinary protein/creatinine ratio.